Boris Finkel

966 total citations
19 papers, 655 citations indexed

About

Boris Finkel is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Boris Finkel has authored 19 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Boris Finkel's work include Schizophrenia research and treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Bipolar Disorder and Treatment (3 papers). Boris Finkel is often cited by papers focused on Schizophrenia research and treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Bipolar Disorder and Treatment (3 papers). Boris Finkel collaborates with scholars based in Israel and Canada. Boris Finkel's co-authors include Bernard Lerer, Ronnen H. Segman, Uriel Heresco‐Levy, A Lerner, A Yakir, T Goltser, A Dorevitch, Mircea Sigal, David A. Greenberg and Abraham Weizman and has published in prestigious journals such as American Journal of Psychiatry, Molecular Psychiatry and Psychopharmacology.

In The Last Decade

Boris Finkel

19 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Finkel Israel 14 342 194 129 121 116 19 655
Joachim Scharfetter Austria 12 280 0.8× 146 0.8× 103 0.8× 63 0.5× 128 1.1× 21 499
A Lerner Israel 11 250 0.7× 134 0.7× 69 0.5× 57 0.5× 75 0.6× 15 463
I‐Ching Lai Taiwan 21 348 1.0× 209 1.1× 267 2.1× 44 0.4× 211 1.8× 37 881
Nabilah I. Chowdhury Canada 15 286 0.8× 120 0.6× 180 1.4× 55 0.5× 160 1.4× 21 685
Timothy L. Holman United States 15 496 1.5× 147 0.8× 152 1.2× 59 0.5× 85 0.7× 22 896
Yoshiteru Takekita Japan 16 321 0.9× 201 1.0× 211 1.6× 59 0.5× 57 0.5× 48 845
Kristina Melkersson Sweden 15 895 2.6× 94 0.5× 170 1.3× 51 0.4× 130 1.1× 42 1.3k
P. J. Perry United States 12 526 1.5× 138 0.7× 101 0.8× 93 0.8× 22 0.2× 20 872
P. Roberto Bakker Netherlands 15 355 1.0× 88 0.5× 58 0.4× 44 0.4× 73 0.6× 29 584
A Howard United States 13 563 1.6× 107 0.6× 79 0.6× 110 0.9× 143 1.2× 17 800

Countries citing papers authored by Boris Finkel

Since Specialization
Citations

This map shows the geographic impact of Boris Finkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Finkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Finkel more than expected).

Fields of papers citing papers by Boris Finkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Finkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Finkel. The network helps show where Boris Finkel may publish in the future.

Co-authorship network of co-authors of Boris Finkel

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Finkel. A scholar is included among the top collaborators of Boris Finkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Finkel. Boris Finkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Finkel, Boris, et al.. (2009). Differences in Metabolic Side-Effects of Typical and Atypical Antipsychotic Treatment in Elderly Individuals with Long-Term Schizophrenia. Hong Kong journal of psychiatry. 19(3). 103. 3 indexed citations
2.
Goodman, Craig, et al.. (2007). Neurocognitive Deterioration in Elderly Chronic Schizophrenia Patients With and Without PTSD. The Journal of Nervous and Mental Disease. 195(5). 415–420. 19 indexed citations
3.
Melamed, Yuval, Adiel Doron, Boris Finkel, et al.. (2007). Israeli Psychiatric Inpatients Go to the Polls. The Journal of Nervous and Mental Disease. 195(8). 705–708. 7 indexed citations
4.
Melamed, Yuval, et al.. (2005). [Pharmacotherapy in schizophrenia--comparison of second generation antipsychotic agents].. PubMed. 144(4). 285–90, 301. 2 indexed citations
5.
Poyurovsky, Michael, Elena Michaelovsky, Amos Frisch, et al.. (2005). COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case–control study. Neuroscience Letters. 389(1). 21–24. 32 indexed citations
6.
Strous, Rael D., Mordechai Weiss, Boris Finkel, et al.. (2005). Video Testimony of Long-Term Hospitalized Psychiatrically Ill Holocaust Survivors. American Journal of Psychiatry. 162(12). 2287–2294. 14 indexed citations
7.
Segman, Ronnen H., T Goltser, Uriel Heresco‐Levy, et al.. (2003). Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. The Pharmacogenomics Journal. 3(5). 277–283. 44 indexed citations
8.
9.
Lerner, Arturo G., et al.. (2002). Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.. PubMed. 39(2). 92–9. 23 indexed citations
10.
Segman, Ronnen H., Uriel Heresco‐Levy, Boris Finkel, et al.. (2001). Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry. 6(2). 225–229. 117 indexed citations
11.
Kodesh, Arad, et al.. (2001). Dose-dependent olanzapine-associated leukopenia: three case reports. International Clinical Psychopharmacology. 16(2). 117–119. 22 indexed citations
12.
Kodesh, Arad, S Katz, A Lerner, Boris Finkel, & Mircea Sigal. (2001). Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder. Journal of Psychopharmacology. 15(1). 58–60. 7 indexed citations
13.
Lerner, A, Marc Gelkopf, Boris Finkel, et al.. (2000). LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. International Clinical Psychopharmacology. 15(1). 35–37. 23 indexed citations
14.
Frisch, Amos, Boris Finkel, Elena Michaelovsky, et al.. (2000). A rare short allele of the serotonin transporter promoter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan origin. Psychiatric Genetics. 10(4). 179–183. 21 indexed citations
15.
16.
Segman, Ronnen H., Uriel Heresco‐Levy, Boris Finkel, et al.. (1999). Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry. 4(3). 247–253. 120 indexed citations
17.
Finkel, Boris, et al.. (1998). Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis. International Clinical Psychopharmacology. 13(3). 133–136. 10 indexed citations
18.
Stein, Avi, et al.. (1996). Single-dose intramuscular ketorolac versus diclofenac for pain management in renal colic. The American Journal of Emergency Medicine. 14(4). 385–387. 19 indexed citations
19.
Barak, Mira, et al.. (1990). CA-15.3, TPA and MCA as markers for breast cancer. European Journal of Cancer and Clinical Oncology. 26(5). 577–580. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Scharfetter Breakdown of academic impact, for papers by A Lerner Breakdown of academic impact, for papers by I‐Ching Lai Breakdown of academic impact, for papers by Nabilah I. Chowdhury Breakdown of academic impact, for papers by Timothy L. Holman Breakdown of academic impact, for papers by Yoshiteru Takekita Breakdown of academic impact, for papers by Kristina Melkersson Breakdown of academic impact, for papers by P. J. Perry Breakdown of academic impact, for papers by P. Roberto Bakker Breakdown of academic impact, for papers by A Howard
Rankless by CCL
2026